TGFB2 and neoplasm: Belagenpumatucel-L (Lucanix) is a vaccine generated from irradiated allogeneic NSCLC cells transfected with an antisense TGFβ2 gene plasmid to enhance adaptive anti-tumor immunity while downregulating TGFβ expression [150].